Efficacy and safety of elbasvir/grazoprevir in treatment-naïve patients with chronic HCV GT 1, GT 4 and GT 6 infection (C-CORAL): a phase III randomized multinational clinical trialLiang Wei, Joseph George, К. В. Жданов et al.|Journal of Hepatology|2017Cited by 10
57. Financial Impact of a Regional Antimicrobial Stewardship Cost Saving Initiative in a Large Integrated Healthcare SystemVān Kính Nguyễn, Brent Footer, Alyssa Christensen et al.|Open Forum Infectious Diseases|2021Cited by 0